California settles lawsuit with Sacramento suburb over affordable housing project [Yahoo! Finance Canada]
Corbus Pharmaceuticals Holdings, Inc. (CRBP)
Last corbus pharmaceuticals holdings, inc. earnings: 3/12 07:05 am
Check Earnings Report
US:NASDAQ Investor Relations:
corbuspharma.com
Company Research
Source: Yahoo! Finance Canada
SACRAMENTO, Calif. (AP) — A Sacramento suburb will have to build more affordable housing for residents at risk of homelessness under a settlement announced Wednesday with California Gov. Gavin Newsom's administration, which comes more than a year after the state alleged in a lawsuit that Elk Grove illegally denied an affordable housing project. The settlement means the city must identify a new site for affordable housing in an area with good access to economic, educational and health resources by July 1, 2025. The state will also have more oversight over the city's approval of affordable housing over the next five years, including by receiving regular updates on the status of proposed projects. Attorney General Rob Bonta, a Democrat, said it should not have taken so long for Elk Grove to agree to build more affordable housing. “Our housing laws are not suggestions,” Bonta said at a news conference Wednesday. “You have to follow them. And if cities try to skirt them — try to avo
Show less
Read more
Impact Snapshot
Event Time:
CRBP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CRBP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CRBP alerts
High impacting Corbus Pharmaceuticals Holdings, Inc. news events
Weekly update
A roundup of the hottest topics
CRBP
News
- Corbus Pharmaceuticals Announces Clinical Data for CRB-701 from Western Dose Escalation Study to be Presented at 2025 ASCO-GUGlobeNewswire
- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $75.00 price target on the stock, down previously from $80.00.MarketBeat
- Corbus Pharmaceuticals to Present at the Guggenheim SMID Cap Biotech ConferenceGlobeNewswire
- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) was upgraded by analysts at StockNews.com to a "sell" rating.MarketBeat
- Corbus Pharmaceuticals Announces that Clinical Data for CRB-701 from Western Dose Escalation Study to be Presented at ASCO GU 2025GlobeNewswire
CRBP
Analyst Actions
- 2/10/25 - HC Wainwright
CRBP
Sec Filings
- 2/14/25 - Form SCHEDULE
- 2/14/25 - Form 144
- 2/14/25 - Form 144
- CRBP's page on the SEC website